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Herpes simplex virus (HSV) DNA is cleaved from concatemers and packaged into capsids in infected cell
nuclei. This process requires seven viral proteins, including UL15 and UL28. UL15 expressed alone displays
a nuclear localization, while UL28 remains cytoplasmic. Coexpression with UL15 enables UL28 to enter nuclei,
suggesting an interaction between the two proteins. Additionally, UL28 copurified with UL15 from HSV-in-
fected cells after ion-exchange and DNA affinity chromatography, and the complex sedimented as a 1:1 hetero-
dimer upon sucrose gradient centrifugation. These findings are evidence of a physical interaction of UL15 and
UL28 and a functional role for UL15 in directing UL28 to the nucleus.
At least seven herpes simplex virus (HSV) genes (UL6,
UL15, UL17, UL25, UL28, UL32, and UL33) encode proteins
required for the cleavage and packaging of HSV DNA into
capsids (1–4, 10, 11, 14, 16–18, 21). These proteins act in
concert to mediate the cleavage event and the packaging of
monomer-length viral genomes into capsids. The coordination
of cleavage and packaging events suggests that these proteins
interact directly, but there is no direct evidence to support this.
The most promising interaction involves UL28 and UL15. Pre-
vious work demonstrated that pseudorabies virus (PRV) UL28
was limited to the cytoplasm in the absence of other viral
proteins (7), and coexpression with HSV UL15 was sufficient
to direct PRV UL28 to nuclei (7).
The possibility that HSV UL28 interacts with HSV UL15
was explored by first establishing that HSV UL15 directs the
nuclear localization of HSV UL28. In Vero cells infected with
HSV(KOS), UL28 accumulated in nuclei (Fig. 1A), consistent
with a direct role in the cleavage and packaging reaction (18).
UL28 was not detected in Vero cells infected with the UL28-
null mutant HSV(gCB) (18) (Fig. 1B). To examine the subcel-
lular distribution of UL28 in the absence of other viral pro-
teins, Vero cells were transfected with plasmid pF19-CMV-
UL28 containing the 3.0-kb BstYI-BstYI fragment from
pECH82 (18) in the vector pF19-CMV (6) as described previ-
ously (7). HSV UL28 remained in the cytoplasm (Fig. 1C),
consistent with the finding that PRV UL28 was also unable to
enter nuclei in the absence of other viral proteins (7). Since
UL28 did not efficiently enter nuclei of cells in the absence of
HSV proteins, the simplest explanation was that another pro-
tein directed UL28 to nuclei. The possibility that UL15 di-
rected UL28 to nuclei was tested. Cells were transfected with
pF19-CMV-UL28 plus pF19-CMV-UL15 as described previ-
ously (7) to express UL28 and UL15, respectively. UL28 was
directed to nuclei in the presence of UL15 (Fig. 1D), suggest-
ing that the two proteins interact. Another HSV cleavage and
packaging protein, UL25, was also coexpressed with UL28 but
did not direct UL28 to nuclei (12). The results suggest that the
transport of UL28 to nuclei by UL15 is conserved among
alphaherpesviruses, consistent with its playing an important
role during infection.
The idea that UL28 interacted directly with another protein
was also suggested by coimmunoprecipitation. Radiolabeled
infected cell extracts were immunoprecipitated with antiserum,
protein A-Sepharose 4B beads (Sigma), separated by sodium
dodecyl sulfate (SDS)–8% polyacrylamide gel electrophoresis
(PAGE), and visualized by autoradiography as described pre-
viously (13) (Fig. 2, lanes D and E). For comparison, [35S]me-
thionine-labeled UL28 was synthesized in reticulocyte lysates
(Promega) from UL28-encoding RNA synthesized in vitro by
T3 RNA polymerase (Ambion) from linearized pECH82 (18)
(Fig. 2, lanes A to C). The H85 anti-UL28 antiserum immu-
noprecipitated an 87-kDa protein from the infected cell extract
(Fig. 2, lane E) as well as the in vitro-synthesized UL28 (Fig. 2,
lane B), whereas the preimmune serum did not (Fig. 2, lanes A
and D). The band of approximately 75 kDa in the in vitro-
expressed reactions is related to UL28 and may result from
premature translation termination or protein degradation.
An 81-kDa protein was radiolabeled during infection and
immunoprecipitated with UL28 from infected cell extracts
(Fig. 2E). The mobility of this protein was consistent with the
expected size of UL15 and not with UL28 products seen in
Western blots (18). However, in order to conclude that the
81-kDa protein coimmunoprecipitating with HSV UL28 was
HSV UL15, a series of protein purification procedures were
performed. Approximately 109 Vero cells were infected with
HSV(KOS) at a multiplicity of infection (MOI) of 5. At 24 h
postinfection the cells were lysed in 10 ml of buffer A (10 mM
Tris-Cl [pH 7.8], 1.5 mM MgCl2, 500 mM EDTA, 10 mM KCl,
1 mM dithiothreitol [DTT], and the following protease inhib-
itors: 1 mM phenylmethylsulfonyl fluoride [PMSF]), 5 mg of
leupeptin/ml, 2.3 mg of ubenimex Bestatin/ml, 3.0 mg of apro-
tinin/ml, 2.7 mg of antipain/ml, and 3.3 mg of pepstatin/ml) by
Dounce homogenization. Pelleted nuclei were lysed in 6 ml of
buffer B (420 mM NaCl, 25 mM Tris-Cl [pH 7.8], 1.5 mM
MgCl2, 25% glycerol, 200 mM EDTA, 1 mM DTT, and the
protease inhibitors). The clarified lysate was adjusted to 300
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mM NaCl, passed through a DEAE-cellulose column to re-
move DNA, and directly loaded onto a 5-ml hydroxyapatite
column. Proteins were eluted with buffer E (125 mM potas-
sium phosphate [pH 7.4], 100 mM EDTA, 1 mM DTT, 100 mM
PMSF, 5% glycerol). The eluate was adjusted to 1 mM DTT
and 25 mM potassium phosphate and then chromatographed
on a Mono-Q HR5/5 column. Proteins were eluted with a
linear gradient of 0 to 500 mM NaCl in buffer F (25 mM
Tris-Cl [pH 7.8], 100 mM EDTA, 1 mM DTT, 100 mM PMSF).
Fractions were screened with anti-UL15 AS7 and anti-UL28
H85 antisera. AS7 is an anti-glutathione S-transferase-UL15
exon 2 serum similar to AS9 (7). The peak fractions containing
UL15 were diluted threefold with 1 mM DTT and loaded onto
a native DNA-cellulose column. Proteins were eluted with a
gradient of 0 to 500 mM NaCl in buffer F into tubes containing
5 mg of bovine serum albumin (BSA) to reduce nonspecific
protein binding to the tubes. Fractions containing UL15 were
pooled and concentrated to 0.5 ml by centrifugation in a Cen-
tricon 30 unit (Amicon). The sample was applied to a 5 to 20%
sucrose gradient in buffer F plus 100 mM NaCl and 1 mM
MgCl2 and then sedimented at 37,000 rpm in a Beckman
SW50.1 rotor for 13 h. Fractions were collected, and proteins
in these fractions were detected after SDS-PAGE by silver
staining (Fig. 3A) and Western blotting (Fig. 3B and C). Silver
staining of the SDS-PAGE-separated proteins revealed several
bands in fractions 9 through 11. The most prominent band, at
67 kDa, corresponded to exogenous BSA carrier protein. Two
other distinct proteins of 87 and 81 kDa were also detected.
The 87-kDa protein was confirmed to be UL28 by Western blot
analysis with H85 antiserum of a duplicate gel (Fig. 3B). The
81-kDa protein was confirmed to be UL15 by Western blotting
with AS7 antiserum of a duplicate gel (Fig. 3C). There were no
immunoreactive bands on the AS7 Western blot consistent
with the size predicted for UL15.5. The peak fractions con-
taining UL15 and UL28 corresponded to a sedimentation mass
near the 157-kDa standard (Fig. 3D) based on the markers for
sedimentation. This sedimentation mass was greater than the
monomer size of either protein and was most consistent with a
UL28-UL15 heterodimer. In contrast, UL25 sedimented as a
monomer from whole infected cell extracts (22). Due to the
low yield of this complex routinely obtained, it is not possible
to accurately estimate its amount or purity.
We have demonstrated that HSV UL28 accumulates within
the nuclei of infected cells yet fails to enter nuclei in the
absence of other viral proteins. Comparison of UL28 with
other proteins required for cleavage and packaging shows con-
siderable variation in their propensities to enter nuclei. Al-
though UL6 and UL15 accumulate in nuclei independently (3,
7, 9, 11, 20, 23), UL25 disperses evenly throughout the cell (7).
UL32 is more prominently localized to the cytoplasm even
during infection (5, 9). The dependence of UL28 on other
proteins to enter the nuclei distinguishes UL28 from the other
cleavage and packaging proteins for which information is avail-
able.
The ability of HSV UL15 to direct UL28 proteins from HSV
and PRV corroborates the substantial conservation of primary
sequences among UL15 and UL28 proteins from different her-
pesviruses, but more importantly it underscores a conservation
of function. Biochemical evidence supports the hypothesis that
UL28 interacts with UL15. The copurification of UL28 with
UL15 through several chromatographic procedures and a su-
crose sedimentation gradient strongly supports the hypothesis
that UL15 and UL28 form a heterodimer.
Independent evidence regarding interactions of UL28 with
UL15 comes from two paths of investigation. Human cytomeg-
alovirus isolates resistant to a compound (TCRB) that inhibits
DNA cleavage and packaging (8, 19) show mutations in their
UL15 and UL28 homologues. The second line of evidence
involves the finding that UL15 (15, 24) and UL28 (24) bind B
capsids in infected cells. In cells infected with a UL28-null
mutant, at least some forms of UL15 fail to bind capsids (15,
24). UL28 still entered nuclei and bound B capsids in cells
infected with UL15 insertion viruses (24), suggesting that trun-
cated UL15 proteins or other proteins transport UL28 to nu-
clei. In summary, the UL28-UL15 protein interaction can be
demonstrated physically in the copurification of a complex and
functionally in the transport of UL28 to the nucleus. The direct
FIG. 1. Fluorescence photomicrographs of UL28 in Vero cells. Vero cells were infected with HSV(KOS) (A) or HSV(gCB) (B) at an MOI of 2 for 12 h or
transfected with plasmids to express UL28 (C) or UL28 plus UL15 (D) for 24 h. Cells were processed to detect UL28 with affinity-purified (13) H85 antiserum (18)
as described previously (7).
FIG. 2. In vitro and in vivo expression of UL28. Equivalent amounts of in
vitro-translated UL28 were immunoprecipitated with either preimmune (A) or
anti-UL28 (B) antisera or left neat (C). Vero cells were infected with HSV(KOS)
at an MOI of 5, radiolabeled with [35S]methionine (New England Nuclear)
between 6 and 9 h postinfection, and then harvested at 16 h as described
previously (13). Cell extracts were immunoprecipitated with either preimmune
(D) or anti-UL28 H85 (E) antisera. The mobilities of molecular mass markers
are indicated to the left. UL28 and the 81-kDa protein are indicated to the right.
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interaction of UL15 with UL28 is consistent with data from
genetic, biochemical, and cellular experiments involving three
different herpesviruses. Many questions regarding the role
of this complex in the cleavage and packaging reaction re-
main.
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